Presentan en México combinación a dosis fija de liberación prolongada para diabetes tipo 2

The page discusses the introduction of a new fixed-dose combination medication for type 2 diabetes in Mexico, specifically featuring sitagliptin and metformin. It highlights the importance of this treatment option in addressing the ongoing public health challenge of diabetes in the country.

Healthcare professionals and diabetes patients in Mexico.

A mention here would suit pharmaceutical brands that offer diabetes medications or health products aimed at diabetes management. It would read naturally in the context of discussing the new medication or during the presentation details.

Summarised from the live page by AI. Traffic figures come from the publisher's own Search Console, last 28 days.